Patel Sandip I
SEC insider (Form 3/4/5 filer). CIK 0001843601. Director at Akari Therapeutics Plc (AKTX) and 2 other issuers. 23 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in TAMPA, FL.
Companies Patel Sandip I has filed insider reports for
- Akari Therapeutics Plc (AKTX): Director
- AtlasClear Holdings, Inc. (ATCH): Director, Officer, CFO and General Counsel
- Peak Bio, Inc. (PKBO): Director
Patel Sandip I
CIK: 0001843601
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect6.2K shares at avg. $0.00$2.474 - Oct 14, 2026AKTX
Akari Therapeutics Plc
ExerciseDirect3.9K shares at avg. $0.00$1.546 - Oct 5, 2026AKTX
Akari Therapeutics Plc
AwardDirect4.3K shares at avg. $7.90$34K - Oct 1, 2026ATCH
AtlasClear Holdings, Inc.
AwardDirectStock Option (right to buy)
777.3K shares- - Sep 25, 2026ATCH
AtlasClear Holdings, Inc.
PurchaseDirect50K shares at avg. $0.20$10K - Sep 25, 2026ATCH
AtlasClear Holdings, Inc.
AwardDirect50K shares at avg. $0.20$10K - Sep 24, 2026ATCH
AtlasClear Holdings, Inc.
PurchaseDirect50K shares at avg. $0.22$11K - Sep 24, 2026ATCH
AtlasClear Holdings, Inc.
AwardDirect50K shares at avg. $0.22$11K - Aug 18, 2026AKTX
Akari Therapeutics Plc
AwardDirect12.1K shares at avg. $7.90$96K - Jul 14, 2026ATCH
AtlasClear Holdings, Inc.
AwardDirectStock Option (right to buy)
45K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 14, 2026 |  AKTX Akari Therapeutics Plc | Exercise | 6,186 | $0.00 | $2 | Direct |
| Oct 14, 2026 | AKTX Akari Therapeutics Plc | Exercise | 3,866 | $0.00 | $2 | Direct |
| Oct 5, 2026 | AKTX Akari Therapeutics Plc | Award | 4,313 | $7.90 | $34,068 | Direct |
| Oct 1, 2026 |  ATCH AtlasClear Holdings, Inc. | Award Stock Option (right to buy) | 777,332 | - | - | Direct |
| Sep 25, 2026 | ATCH AtlasClear Holdings, Inc. | Purchase | 50,000 | $0.20 | $9,875 | Direct |
| Sep 25, 2026 | ATCH AtlasClear Holdings, Inc. | Award | 50,000 | $0.20 | $9,875 | Direct |
| Sep 24, 2026 | ATCH AtlasClear Holdings, Inc. | Purchase | 50,000 | $0.22 | $10,865 | Direct |
| Sep 24, 2026 | ATCH AtlasClear Holdings, Inc. | Award | 50,000 | $0.22 | $10,865 | Direct |
| Aug 18, 2026 | AKTX Akari Therapeutics Plc | Award | 12,100 | $7.90 | $95,578 | Direct |
| Jul 14, 2026 | ATCH AtlasClear Holdings, Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
1-10 of 23 transactions